Overview

Study to Evaluatethe Bioavailability and Food Effect Lenalidomide as an Oral Suspension

Status:
Completed
Trial end date:
2015-09-23
Target enrollment:
Participant gender:
Summary
This study will evaluate the amount of drug that reaches the circulation when a subject takes the test (liquid) formulation compared to the reference (capsule) formulation. The study will also examine the effect of a high fat meal on the levels of drug in blood.
Phase:
Phase 1
Details
Lead Sponsor:
Celgene
Celgene Corporation
Treatments:
Lenalidomide
Thalidomide